<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82406">
  <stage>Registered</stage>
  <submitdate>12/11/2007</submitdate>
  <approvaldate>19/11/2007</approvaldate>
  <actrnumber>ACTRN12607000594426</actrnumber>
  <trial_identification>
    <studytitle>Using conversational computer technology to improve diabetes management: a randomised controlled trial.</studytitle>
    <scientifictitle>A randomised controlled trial to determine the impact of using conversational computer technology on clinical, self-management and behavioural outcomes in patients with type 2 diabetes.</scientifictitle>
    <utrn />
    <trialacronym>TLC Diabetes.</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Type 2 diabetes.</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Subjects receiving the Telephone Linked Care (TLC) intervention will continue to receive their usual medical care. In addtion they will receive the TLC intervention consisting of a computer equipped with sophisticated speech recognition and voice processing software, a database and a control system. Users call into the system from their regular telephone or mobile phone. TLC interviews and converses with the user via pre-recorded statements and questions. It listens to answers and records them in the database and uses them to provide feedback and tailor current and future conversations. Prior to each call, users will also upload their most recent glucose meter results via a data transmitter connected to a dedicated mobile phone. The delivery of the TLC Program will be complemented by a Case Manager. Participants will call the TLC System on the same day, weekly, for 6 months.</interventions>
    <comparator>Usual care from GP and/or endocrinologist.</comparator>
    <control>Active</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Quality of life as measured by questionnaire.</outcome>
      <timepoint>6 and 12 months.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>HbA1c as measured by venous blood sampling.</outcome>
      <timepoint>6 and 12 months.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Other clinical outcomes (insulin sensitivity, blood pressure, Body Mass Index, lipid profile). These will be measured by venous blood sampling and anthropometric measurement.</outcome>
      <timepoint>6 and 12 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Diagnosis of type 2 diabetes. 2. Stable diabetes therapy for previous 3 months. 3. Ability to converse in and understand English via the telephone. 4. Having access to a telephone. 5. Haemoglobin A1C (HbA1c), pathology test, equal to or greater than 7.5. 6. Live within the greater Brisbane area</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Enrollment in another significiant research study. 2. Presence of dementia or other cognitive impairment. 3. Pregnancy.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Subjects will be recruited using multiple methods including newspaper adverts, hospital outpatient departments and Diabetes Australia Queensland newsletters. Allocation concealment is by way of opaque sealed envelopes.</concealment>
    <sequence>Simple computer generated random number sampling.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/02/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>340</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Monash University</primarysponsorname>
    <primarysponsoraddress>Department of Epidemiology and Preventive Medicine
Monash University
Alfred Hospital Campus
Level 3 (Burnet Tower)
89 Commercial Road
Melbourne VIC 3004</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC</fundingname>
      <fundingaddress>National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Princess Alexandra Hospital</sponsorname>
      <sponsoraddress>University of Queensland Centre for Diabetes and Endocrine Research
Ipswich Road
Woolloongabba QLD 4102</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>Centre for Online Health</othercollaboratorname>
      <othercollaboratoraddress>Royal Childrens Hospital
Herston QLD 4029</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this study is to evaluate the impact of a computer-controlled, automated and interactive telephone system on the self management of people with type 2 diabetes.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Monash University Human Research Ethics Committee</ethicname>
      <ethicaddress>Monash University
Building 3E
Wellington Road
Clayton VIC 3800</ethicaddress>
      <ethicapprovaldate>14/03/2007</ethicapprovaldate>
      <hrec>CF07/0313 - 2007/0102</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Princess Alexandra Human Research Ethics Committee</ethicname>
      <ethicaddress>Ipswich Road
Woolloongabba Qld 4102</ethicaddress>
      <ethicapprovaldate>13/09/2007</ethicapprovaldate>
      <hrec>2007/029</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Professor Brian Oldenburg</name>
      <address>Department of Epidemiology and Preventive Medicine
Monash University
Alfred Hospital Campus
Level 3 (Burnet Tower)
89 Commercial Road
Melbourne VIC 3004</address>
      <phone>+61 3 99030046</phone>
      <fax />
      <email>brian.oldenburg@med.monash.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Brian Oldenburg</name>
      <address>Department of Epidemiology and Preventive Medicine
Monash University
Alfred Hospital Campus
Level 3 (Burnet Tower)
89 Commercial Road
Melbourne VIC 3004</address>
      <phone>+61 3 99030046</phone>
      <fax />
      <email>brian.oldenburg@med.monash.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Brian Oldenburg</name>
      <address>Department of Epidemiology and Preventive Medicine
Monash University
Alfred Hospital Campus
Level 3 (Burnet Tower)
89 Commercial Road
Melbourne VIC 3004</address>
      <phone>+61 3 99030046</phone>
      <fax />
      <email>brian.oldenburg@med.monash.edu.au</email>
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>